Mon 11 November 2024
Reflection and celebration as AdPha marks ‘monumental’ year
Amid the milestones, Advanced Pharmacy Australia reflects on identity and change in 2024 Annual Report
Advanced Pharmacy Australia (AdPha) has released its 2024 Annual Report highlighting investment in member priorities, inclusion of technicians, advocacy and awareness wins, and growth in membership and Specialty Practice participation, while celebrating awardwinning members and its largest ever Honour Roll.
AdPha President Tom Simpson FANZCAP (Lead&Mgmt) says the Board’s leadership of the transition to a new brand and trading name defined 2024, generating important conversations among the membership about the evolution of identity.
‘Hospital pharmacy has never stood still, and neither can we.
‘How we represent current and prospective members, and how we explain the current and future impact of hospital pharmacy, is key to strengthening our advocacy, delivering against our mission and expanding opportunities for our profession.
‘Through our new branding we signal where hospital pharmacy is going, rather than reflecting what it has been. A driving force of hospital-informed change that is increasingly delivered in diverse care settings.
‘This is what AdPha members continue to do so well: work, innovate and deliver safer and more effective care to Australians, at their most unwell, in and around our hospitals.’
A number of milestones are noted in the report, including a new high water mark for membership, which is approaching 5,700; attendance of more than 7,000 across 75 national events of the AdPha CPD program; nearly 2,500 pharmacists recognised through the Australian and New Zealand College of Advanced Pharmacy (ANZCAP); and an average of more than 650 members in each of 33 Specialty Practice Groups, now hosted on a dedicated platform and backed by AdPha’s first app, released in August.
‘We are as strong as the projects and platforms that bring us together.
‘The 2024 Honour Roll is our largest since its introduction in 2018, totaling almost 400 members who have contributed through state and territory Branch Committees, Specialty Practice Leadership Committees, and groups steering key AdPha programs, projects and events across advocacy, education, workforce development, as well as the Medicines Management national conference.
‘Looking ahead, specialisation in our profession will continue, exemplified by our Specialty Practice program, which now features four specialty groups with membership of more than 1,000.
‘A new blueprint will be born next week when we release the fully revised and updated Clinical Pharmacy Standards, before gathering for Medicines Management 2024 (MM2024) in Adelaide.
‘And we look to the future under a broader and more inclusive banner that embraces the reality that our collaborative impact extends to pharmacy peers and interdisciplinary colleagues.’
‘The Board thanks every member – at all levels of participation – for a monumental year, and there is so much more to come.’
Download the 2024 AdPha Annual Report.